CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- 4 Planned sale CEO & President sold 15,202 shares at $505.00 ($7,677,010)
- 4 Planned sale EVP and CMO sold 2,280 shares at $488.46 ($1,113,689)
- 4 Planned sale CEO & President sold 15,202 shares at $497.00 ($7,555,394)
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP and CMO sold 2,280 shares at $487.34 ($1,111,135)
- 4 Planned sale EVP and CMO sold 2,280 shares at $471.72 ($1,075,522)
- 4 Planned sale EVP and CMO sold 2,280 shares at $478.00 ($1,089,840)
- 4 Planned sale EVP, Chief Technical Ops. Off. sold 7,288 shares at $478.00 ($3,483,664)
- 4 Gift EVP Chief Patient & Ext Af Off gave 4,600 shares (gift)
- 4 Planned sale EVP & Chief Financial Officer sold 3,250 shares at $460.00 ($1,495,000)
- 4 Planned sale EVP, Chief Reg. & Quality Off. sold 2,175 shares at $460.00 ($1,000,500)
- 4 Planned sale EVP, Chief Reg. & Quality Off. sold 4,600 shares at an average $441.99 ($2,033,159)
- 4 Planned sale EVP and CMO sold 2,280 shares at $445.56 ($1,015,877)
- 4 Planned sale EVP & Chief Financial Officer sold 3,250 shares at $454.79 ($1,478,068)
- 4 Planned sale CEO & President sold 1,565 shares at $457.00 ($715,205)
- 4 Planned sale Director sold 7,073 shares at $448.00 ($3,168,704)
- 4 Planned sale CEO & President sold 15,202 shares at $447.00 ($6,795,294)
- 4 Planned sale EVP Chief Patient & Ext Af Off sold 32 shares at $430.93 ($13,790)
- 4 Planned sale EVP, COO sold 69 shares at $430.93 ($29,734)
- 4 Planned sale EVP, Chief Scientific Officer sold 54 shares at $430.93 ($23,270)
Page 12 of 129 · 2,568 filings